Summit Securities Group’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.03K	Buy	2,122 +1,967	+1,269%	+$2.81K	﹤0.01%	876
2025 Q1	$248	Buy	+155	New	+$248	﹤0.01%	596
2024 Q4	–	Sell	-143	Closed	-$1K	–	545
2024 Q3	$1K	Buy	+143	New	+$1K	﹤0.01%	387